5/7/25 |
Daiichi (4568) |
Enhertu for HER2+ Breast Cancer |
Subscribers Only |
Subscribers Only |
Subscribers Only |
5/4/25 |
Sylentis |
SYL1801 for Wet Age-Related Macular Degeneration (Wet AMD) (Ophthalmology) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
5/1/25 |
Genmab (GMAB) |
Epkinly for Follicular Lymphoma (FL) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
4/30/25 |
GSK (GSK) |
Nucala Liquid Formulation for Chronic Obstructive Pulmonary Disease (COPD) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
4/26/25 |
Pfizer (PFE) |
Sasanlimab for Bladder Cancer |
Subscribers Only |
Subscribers Only |
Subscribers Only |